Neoreviews
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-Letters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maisels, M. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Maisels, M. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

NeoReviews Vol.7 No.5 2006 e217
© 2006 American Academy of Pediatrics

Historical Perspectives: Transcutaneous Bilirubinometry

The first 300 words of the full text of this article appear below.


    Introduction
 
When the bilirubin concentration in the serum increases, bilirubin is deposited in the skin and subcutaneous tissues, (1) producing the (yellow) physical sign of jaundice or icterus. There is a well-established relationship between the total serum bilirubin (TSB) concentration and the intensity of jaundice, and the possibility of quantifying the bilirubin value by assessing skin color is not new. This relationship was documented in 1913 by Ylppö, (2) although he measured the bilirubin concentration in whole blood, not serum. The next major advance was the recognition that bilirubin could be toxic, that its toxicity was related to its concentration, and that it was possible to treat hyperbilirubinemia (and prevent neurologic damage) with exchange transfusion. (3) Pediatricians measured TSB in infants if jaundice appeared early (in the first 24 hours after birth) or appeared excessive for the infant’s age. Unfortunately, it is neither possible, nor desirable, to measure the serum bilirubin daily in every infant for the first week after birth. Accordingly, clinicians have used the clinical sign of jaundice as the trigger for deciding when to measure the TSB concentration.


    The Clinical Diagnosis of Hyperbilirubinemia
 
     How Good is the Visual Assessment of Jaundice?
Although there is a clear and semiquantitative relationship between the yellowness of the skin and the TSB, the variations in color perception by the human eye, differences in neonatal skin pigmentation, and variations in both the intensity and color of the available light affect the ability to estimate the TSB by assessing the degree of jaundice in a newborn. In 1941, Davidson and associates (4) described their experience evaluating the degree of jaundice in 99 infants. They examined each infant in daylight, applying a tongue depressor to the mucous membrane of the lower jaw as well as the skin of the forehead or the chin. Based on the icterus they observed following . . . [Full Text of this Article]

M. Jeffrey Maisels, MB, BCh*

* Department of Pediatrics, William Beaumont Hospital, Royal Oak, Mich


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
PediatricsHome page
M. J. Maisels, V. K. Bhutani, D. Bogen, T. B. Newman, A. R. Stark, and J. F. Watchko
Hyperbilirubinemia in the Newborn Infant >=35 Weeks' Gestation: An Update With Clarifications
Pediatrics, October 1, 2009; 124(4): 1193 - 1198.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
S. N. El-Beshbishi, K. E. Shattuck, A. A. Mohammad, and J. R. Petersen
Hyperbilirubinemia and Transcutaneous Bilirubinometry
Clin. Chem., July 1, 2009; 55(7): 1280 - 1287.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
D De Luca, E Zecca, M Corsello, E Tiberi, C Semeraro, and C Romagnoli
Attempt to improve transcutaneous bilirubinometry: a double-blind study of Medick BiliMed versus Respironics BiliCheck
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2008; 93(2): F135 - F139.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Academy of Pediatrics.